Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia

Introduction

• JM Rowe

Treatment of relapsed and refractory acute myelogenous leukemia

• EH Estey

Introduction to Janet D Rowley

• E Beutler

Monoclonal antibodies to the myeloid stem cells: therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate

• ID Bernstein

Transplantation of hematopoietic stem cells from alternate donors in acute myelogenous leukemia

• C Anasetti

Advances in the treatment of graft-versus-host disease

• GB Vogelsang

New agents for acute myelogenous leukemia

• JA Zwiebel

Differentiation therapy in acute myelogenous leukemia (non-APL)

• S Waxman

Treatment of acute myelogenous leukemia in older adults

• JM Rowe

Use of thrombopoietic growth factors in acute leukemia

• K Kaushansky

Is there a best transplant conditioning regimen for acute myeloid leukemia?

• FR Appelbaum

Molecular genetics in acute leukemia

• JD Rowley

Novel mechanisms of drug resistance in leukemia

• DD Ross